Status: affected by circulating vaccine-derived poliovirus type 2 (cVDPV2)
Senegal is affected by cVDPV2, linked to an outbreak originating in Nigeria. GPEI partners, including through our regional and country offices, are continuing to assist Egyptian health authorities in conducting a complete investigation, including to ascertain more clearly the origin/source of the isolated virus, and assess potential risk of spread within the country as well as internationally.
Polio this week in Senegal
- No case of circulating vaccine-derived poliovirus type 2 (cVDPV2) was reported this week.
International Health Regulations
Senegal is classified by the International Health Regulations (IHR) as a state infected with cVDPV2, with or without evidence of local transmission. It is therefore subject to Temporary Recommendations issued by the International Health Regulations Emergency Committee on Polio Eradication (issued as of 1 November 2022).
WHO’s International Travel and Health recommends that all travellers to polio-affected areas be fully vaccinated against polio. Residents (and visitors for more than 4 weeks) from infected areas should receive an additional dose of OPV or inactivated polio vaccine (IPV) within 4 weeks to 12 months of travel.